Neiges Biotechnologies

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
NAICS	541714
Employees	1-10

Key Contact at Neiges Biotechnologies

Andrew T. Song

Chief Executive Officer

About Neiges Biotechnologies

Pioneering a new era in preclinical to clinical translation in gastrointestinal therapeutics — enabled by our cutting edge NAM platform. Our New Approach Methodologies (NAM) platform is an entirely human (no animals) transmural intestine with immune cells, where a hundred of these miniature guts can fit in your hand. We are here to change how reliably a preclinical therapeutic asset translates to a clinical outcome and deliver meaningful improvements in patients' lives.

Neiges Biotechnologies revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Neiges Biotechnologies has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Neiges Biotechnologies has never raised funding before.

Frequently asked questions

Neiges Biotechnologies is located in XX.

Neiges Biotechnologies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Neiges Biotechnologies

Andrew T. Song

Chief Executive Officer

4.8

40,000 users